Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Angiodynamics Inc (ANGO)

Angiodynamics Inc (ANGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 388,609
  • Shares Outstanding, K 40,607
  • Annual Sales, $ 303,910 K
  • Annual Income, $ -184,350 K
  • EBIT $ -38 M
  • EBITDA $ 149 M
  • 60-Month Beta 0.58
  • Price/Sales 1.27
  • Price/Cash Flow 2.22
  • Price/Book 2.07

Options Overview Details

View History
  • Implied Volatility 69.31% ( +1.39%)
  • Historical Volatility 40.18%
  • IV Percentile 48%
  • IV Rank 30.75%
  • IV High 199.19% on 07/09/24
  • IV Low 11.62% on 06/10/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 6
  • Volume Avg (30-Day) 30
  • Put/Call OI Ratio 0.81
  • Today's Open Interest 837
  • Open Int (30-Day) 868

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 05/31/25
See More
  • Average Estimate -0.13
  • Number of Estimates 3
  • High Estimate -0.09
  • Low Estimate -0.20
  • Prior Year -0.06
  • Growth Rate Est. (year over year) -116.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.55 +8.89%
on 05/07/25
9.79 -4.90%
on 05/21/25
+0.01 (+0.11%)
since 04/22/25
3-Month
8.27 +12.58%
on 03/11/25
11.72 -20.56%
on 04/02/25
-1.02 (-9.87%)
since 02/21/25
52-Week
5.47 +70.20%
on 07/09/24
13.50 -31.04%
on 01/30/25
+2.99 (+47.31%)
since 05/22/24

Most Recent Stories

More News
AngioDynamics Stock Rockets On Upbeat Q3, Improved Full-Year Guidance – But Retail Sentiment Plummets

The medical technology company now expects net sales to be $285 to $288 million for the fiscal year 2025, up from previously issued guidance of $282 to $288 million, owing to increased medical technology...

VTI : 288.24 (+0.51%)
ANGO : 9.33 (-2.51%)
IWM : 204.04 (+0.41%)
AngioDynamics: Fiscal Q3 Earnings Snapshot

AngioDynamics: Fiscal Q3 Earnings Snapshot

ANGO : 9.33 (-2.51%)
AngioDynamics: Fiscal Q2 Earnings Snapshot

AngioDynamics: Fiscal Q2 Earnings Snapshot

ANGO : 9.33 (-2.51%)
Here's Why You Should Add Accuray Stock in Your Portfolio Now

Accuray Incorporated ARAY is well-poised for growth in the coming quarters, courtesy of continued robust demand for its products. The optimism, led by robust international performance in the first quarter...

AXGN : 11.03 (-3.25%)
ARAY : 1.5900 (-1.85%)
MASI : 150.01 (+0.42%)
ANGO : 9.33 (-2.51%)
Why AngioDynamics Stock Is Crashing Today

Investors didn't like the medical technology company's fiscal 2025 Q1 update.

ANGO : 9.33 (-2.51%)
AngioDynamics: Fiscal Q1 Earnings Snapshot

AngioDynamics: Fiscal Q1 Earnings Snapshot

ANGO : 9.33 (-2.51%)
New Strong Buy Stocks for September 30th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Marex Group plc MRX: This financial services platform provider has seen the Zacks Consensus Estimate for its current year earnings...

MRX : 43.62 (+0.60%)
OPRA : 18.01 (+0.56%)
ATAT : 33.25 (+10.17%)
ANGO : 9.33 (-2.51%)
PAM : 82.05 (+0.74%)
New Strong Buy Stocks for September 13th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Arcturus Therapeutics Holdings Inc. ARCT: This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings...

MHO : 105.88 (-0.48%)
ANGO : 9.33 (-2.51%)
ARCT : 12.70 (+4.53%)
PAM : 82.05 (+0.74%)
FMBH : 35.53 (-0.84%)
AngioDynamics: Fiscal Q4 Earnings Snapshot

AngioDynamics: Fiscal Q4 Earnings Snapshot

ANGO : 9.33 (-2.51%)
AngioDynamics: Fiscal Q3 Earnings Snapshot

AngioDynamics: Fiscal Q3 Earnings Snapshot

ANGO : 9.33 (-2.51%)

Business Summary

AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies...

See More

Key Turning Points

3rd Resistance Point 10.15
2nd Resistance Point 9.97
1st Resistance Point 9.77
Last Price 9.33
1st Support Level 9.39
2nd Support Level 9.21
3rd Support Level 9.01

See More

52-Week High 13.50
Fibonacci 61.8% 10.43
Fibonacci 50% 9.48
Last Price 9.33
Fibonacci 38.2% 8.54
52-Week Low 5.47

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar